Introduction
Central sleep apnea is diagnosed by identifying a pattern of breathing during sleep that reflects a failure of the brain’s respiratory control rather than a blockage of the airway. In this condition, breathing pauses occur because the brain does not send a consistent enough signal to the muscles that drive ventilation. That distinction matters because central sleep apnea is managed differently from obstructive sleep apnea, which is caused by physical collapse of the upper airway.
Accurate diagnosis is important for several reasons. Central sleep apnea may be linked to heart failure, stroke, opioid use, high-altitude exposure, or neurologic disease, and the breathing abnormality itself can worsen oxygen levels, disrupt sleep architecture, and contribute to daytime impairment. Because the underlying cause may be serious, clinicians aim not only to confirm the sleep-related breathing pattern but also to determine why it is occurring.
Recognizing Possible Signs of the Condition
Suspicion of central sleep apnea usually begins with symptoms reported by the patient or observed by a bed partner. These can include repeated pauses in breathing during sleep, breathing that starts and stops in a cyclical pattern, and restless or fragmented sleep. Unlike obstructive sleep apnea, snoring may be less prominent, although it can still be present if a patient has mixed forms of sleep-disordered breathing.
Daytime symptoms can also provide clues. People may report excessive sleepiness, morning headaches, trouble concentrating, unrefreshing sleep, or fatigue that does not improve with rest. Some individuals notice awakening short of breath or feeling that their breathing has become irregular during the night. In more severe cases, the person may have witnessed apneic episodes, especially if a family member or partner has observed long pauses followed by resumed breathing.
Clinicians become especially alert when these symptoms occur in a patient with heart failure, prior stroke, chronic opioid use, atrial fibrillation, neurologic disease, or kidney disease. Central sleep apnea is also considered in people who recently began positive airway pressure therapy and develop persistent residual events, because treatment-emergent central sleep apnea can appear once obstructive events are partially relieved.
Medical History and Physical Examination
Diagnosis begins with a careful history. A clinician will ask when symptoms started, how often breathing interruptions occur, whether they are worse in certain positions or at certain times of night, and whether the patient has insomnia or frequent awakenings. The presence of snoring, choking, or gasping is still relevant, but the pattern of breathing pauses is often more useful in distinguishing central from obstructive disease. The clinician will also ask about medications, especially opioids, sedatives, and other drugs that can suppress respiratory drive.
Medical history is critical because central sleep apnea is frequently secondary to another disorder. Heart failure, stroke, neurologic conditions, renal failure, and chronic use of respiratory depressants all raise suspicion. High-altitude exposure or recent changes in sleep environment may also matter. If the patient has been treated for sleep apnea before, the clinician will review prior sleep study results, response to therapy, and any evidence of persistent central events.
Physical examination is not diagnostic by itself, but it helps identify contributing conditions and competing explanations. Clinicians may check body weight, blood pressure, heart rate, lung findings, and signs of heart failure such as edema or elevated neck veins. Neurologic examination may be used to look for focal deficits or other evidence of prior brain injury. Features that point strongly to upper airway obstruction, such as a crowded oropharynx, large tonsils, or marked obesity, may suggest that obstructive sleep apnea is also present, which is common.
Diagnostic Tests Used for Central Sleep Apnea
The definitive diagnosis is usually made with a sleep study, most often overnight polysomnography. This is the standard test because it records both sleep and breathing in a way that allows clinicians to determine whether breathing pauses occur because of absent respiratory effort or because the airway is blocked. During polysomnography, sensors measure airflow, chest and abdominal movement, oxygen saturation, heart rhythm, sleep stage, and arousals from sleep. If airflow stops while respiratory effort also stops, the event is classified as central apnea. If effort continues but airflow stops, the event is obstructive apnea.
Polysomnography also quantifies severity. The apnea-hypopnea index, or AHI, counts the number of apneas and hypopneas per hour of sleep, while the central apnea index counts specifically the number of central apneas. A diagnosis may be supported when central events are frequent enough and match the clinical picture. The study also shows whether central events cluster at certain sleep stages or whether a periodic breathing pattern is present.
In some cases, home sleep apnea testing may be used initially, but it is less reliable for diagnosing central sleep apnea because many portable devices do not directly measure sleep stage or respiratory effort as completely as in-laboratory testing. For that reason, if central sleep apnea is suspected, full polysomnography is generally preferred.
Laboratory tests are not used to diagnose sleep apnea directly, but they are often important in finding causes or contributing factors. Blood tests may include arterial or venous blood gas analysis in select cases, especially if hypoventilation or abnormal carbon dioxide regulation is suspected. Clinicians may order thyroid function tests, kidney function tests, and cardiac markers or natriuretic peptides if heart disease is a concern. These tests help identify metabolic or systemic problems that could alter breathing control during sleep.
Imaging studies may be used when a structural or neurologic cause is possible. Brain MRI or CT can help evaluate prior stroke, brainstem lesions, tumors, or other abnormalities in areas that regulate breathing. Chest imaging may be appropriate if cardiopulmonary disease is suspected. Echocardiography is especially important in patients with heart failure because reduced cardiac function is strongly associated with central sleep apnea and may influence treatment choices.
Functional tests can also contribute to the workup. Overnight oximetry may show repeated oxygen desaturations, though it cannot distinguish central from obstructive events on its own. Capnography or transcutaneous carbon dioxide monitoring, when available during sleep testing, can provide information about ventilation and instability in carbon dioxide levels. In some patients, clinicians may use pulmonary function testing to assess underlying lung disease or to help explain abnormal breathing patterns.
Tissue examination is not a routine part of diagnosing central sleep apnea. Biopsy or direct tissue evaluation is generally unnecessary unless a separate disease process is suspected, such as a tumor or inflammatory condition affecting the nervous system. In practice, diagnosis relies on physiologic testing and evaluation of underlying medical conditions rather than on tissue sampling.
Interpreting Diagnostic Results
Doctors interpret results by combining the sleep study pattern with the broader clinical context. Central sleep apnea is confirmed when sleep testing shows repeated apneas or hypopneas that occur without respiratory effort and are not better explained by obstruction. The pattern often includes a reduced or absent drive to breathe, possibly followed by resumption of breathing in cycles. In some forms, the periodic breathing pattern is especially recognizable, with waxing and waning ventilation over time.
Interpretation also depends on how many events are central versus obstructive. Many patients have mixed sleep apnea, and some have mostly obstructive events with a smaller number of central events. Clinicians do not label the disorder as central sleep apnea unless central events are predominant or clinically significant. They also consider whether central events were present before treatment or appeared after therapy began, since treatment-emergent central sleep apnea may change the diagnostic impression.
Test results are also reviewed for oxygen desaturation, sleep fragmentation, and the degree of daytime sleep disruption. A person with only a few central events may not meet diagnostic thresholds, whereas someone with frequent events, repeated arousals, and evidence of underlying disease may require further evaluation even if symptoms are modest. The diagnosis is therefore not based on a single number alone, but on the combination of event type, frequency, physiologic impact, and associated illness.
Conditions That May Need to Be Distinguished
Several other disorders can resemble central sleep apnea or appear alongside it. Obstructive sleep apnea is the most important distinction because it is much more common and involves upper airway collapse rather than loss of respiratory drive. Sleep studies separate the two by measuring whether respiratory effort persists during the event. Mixed sleep apnea, which includes features of both, can complicate interpretation.
Periodic breathing from heart failure can mimic central sleep apnea and is often considered part of the same spectrum. Cheyne-Stokes respiration, a form of periodic breathing with a crescendo-decrescendo pattern, is commonly associated with heart failure or stroke. Distinguishing these entities matters because they may suggest an underlying cardiac or neurologic problem that should be addressed directly.
Hypoventilation syndromes may also be considered, especially in patients with obesity, neuromuscular weakness, or medication-related respiratory suppression. These conditions tend to show sustained inadequate ventilation rather than discrete central pauses. Neurologic disorders, seizures, and rare brainstem abnormalities may also be evaluated when the breathing pattern is unusual or when other signs point away from primary sleep apnea. Finally, insomnia, parasomnias, and nocturnal panic can produce awakenings and perceived breathing discomfort, but they do not show the characteristic respiratory pattern on polysomnography.
Factors That Influence Diagnosis
Several patient factors affect how central sleep apnea is diagnosed and how quickly it is recognized. Age matters because central events are more common in older adults, especially when cardiovascular or neurologic disease is present. Severity of symptoms also influences evaluation: a patient with marked sleep disruption, daytime sleepiness, or concerning witnessed apneas will usually be studied more promptly than someone with mild, nonspecific fatigue.
Coexisting conditions shape the diagnostic pathway. Heart failure increases the likelihood of central sleep apnea and may prompt echocardiography or other cardiac testing. Stroke history or focal neurologic symptoms may lead to brain imaging. Opioid use is an important clue because it can suppress the respiratory centers in the brain and produce central apneas or hypoventilation. Kidney disease, atrial fibrillation, and high-altitude exposure can also alter the interpretation of sleep study findings.
Medication use, body habitus, and prior sleep apnea treatment also matter. A patient with obesity and loud snoring may have significant obstructive disease in addition to central events. Someone already using positive airway pressure therapy may have treatment-emergent central apneas that need reassessment rather than a completely new diagnosis. Because of these variables, clinicians often use a stepwise diagnostic approach rather than relying on symptoms alone.
Conclusion
Central sleep apnea is diagnosed by combining clinical suspicion with objective sleep testing and targeted evaluation for underlying disease. Symptoms and history may raise concern, but confirmation usually requires polysomnography, which shows that breathing stops because respiratory effort is absent rather than because the airway is blocked. Additional blood tests, imaging, and functional studies may be used to identify associated heart, brain, lung, metabolic, or medication-related causes.
The diagnostic process is careful because central sleep apnea often reflects an abnormality in respiratory control rather than an isolated sleep disorder. By distinguishing it from obstructive sleep apnea, mixed apnea, hypoventilation, and other look-alike conditions, clinicians can reach a more accurate diagnosis and determine what underlying problem needs attention. That combination of physiologic measurement and medical context is what makes the diagnosis reliable.